The National Institute of Neurological Disorders and Stroke (NINDS) has selected SMA to serve as the prototype for a translational research project that is expected to yield drug candidates for investigational new drug application filings by 2007.
After law school Mr. Goan worked as In - House Counsel for Pharmakon Labs, Inc., where he assisted in the filings of new drugapplications and developed standard operating procedures in compliance with the Federal Code of Regulations.